Qdrant's $50M Series B and version 1.17 release make the case that agentic AI didn't simplify vector search — it scaled the ...
For both the fourth quarter and full year 2025, the increases in R&D expenses were primarily due to higher clinical trial and manufacturing costs associated with the development of soquelitinib as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results